Flawed Scheme to Lower Prescription Drug Prices Would Do the Opposite
IP Watchdog
SEPTEMBER 16, 2022
In a recent letter to Department of Health and Human Services Secretary Xavier Becerra, 100 congressional lawmakers urged him to use his administrative authorities to leverage various intellectual property-related laws as a means of implementing price controls on patented drugs.
Let's personalize your content